Neurovalens specializes in non-invasive medical devices aimed at addressing significant health issues, particularly chronic insomnia and Type 2 diabetes. Their flagship product, Modius Sleep, is an FDA-cleared device designed to treat chronic insomnia through electrical vestibular nerve stimulation (VeNS). This technology works by delivering gentle electrical impulses to the vestibular nerve, which connects to the hypothalamus, a brain region crucial for regulating sleep patterns. Clinical trials have shown promising results, with 95% of participants reporting improved sleep after four weeks of use. The device is designed for home use, requiring only 30 minutes of wear each evening, making it a convenient alternative to traditional drug-based treatments.

In addition to Modius Sleep, Neurovalens has developed a neurostimulation wearable device aimed at helping individuals with Type 2 diabetes improve their blood sugar control. This device also employs non-invasive techniques, delivering electrical impulses to the vestibular nerve to influence glycemic regulation. The clinical trial for this product involved 182 participants and focused on assessing its safety and effectiveness over a six-month period. Neurovalens' commitment to advancing health technology is further underscored by their recognition from the National Sleep Foundation, which awarded them the 2024 SleepTech® Award for their innovative contributions to sleep health and wellness.

United Kingdom

Based in Belfast, Neurovalens is a global health-tech company that creates non-invasive neurostimulation products used to solve some of the world's greatest health challenges!

Modius is the first product from Neurovalens which successfully launched in August 2017 on Indiegogo. Modius was designed to help improve the lives of people who struggle with their weight by using neuro-technology to help make weight loss easier.

Neurovalens

Company Details